Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-26 @ 2:46 AM
Study NCT ID:
NCT00306202
Status:
COMPLETED
Last Update Posted:
2021-02-26
First Post:
2006-03-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2011-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-22
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-21
First Submit QC Date:
None
Study First Post Date:
2006-03-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-06-11
Results First Submit QC Date:
None
Results First Post Date:
2012-07-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-24
Last Update Post Date:
2021-02-26
Last Update Post Date Type:
ACTUAL